New York Life Investment Management »

Atea Pharmaceuticals shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $314k 103k 3.05
2023-09-30 $319k 106k 3.00
2023-06-30 $460k 123k 3.74
2023-03-31 $487k 145k 3.35
2022-12-31 $378k 79k 4.81
2022-09-30 $397k 70k 5.69
2022-06-30 $459k 65k 7.11